1. Home
  2. MNKD vs NBTB Comparison

MNKD vs NBTB Comparison

Compare MNKD & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • NBTB
  • Stock Information
  • Founded
  • MNKD 1991
  • NBTB 1856
  • Country
  • MNKD United States
  • NBTB United States
  • Employees
  • MNKD N/A
  • NBTB N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • NBTB Major Banks
  • Sector
  • MNKD Health Care
  • NBTB Finance
  • Exchange
  • MNKD Nasdaq
  • NBTB Nasdaq
  • Market Cap
  • MNKD 1.9B
  • NBTB 2.2B
  • IPO Year
  • MNKD 2004
  • NBTB N/A
  • Fundamental
  • Price
  • MNKD $6.01
  • NBTB $47.86
  • Analyst Decision
  • MNKD Buy
  • NBTB Buy
  • Analyst Count
  • MNKD 6
  • NBTB 5
  • Target Price
  • MNKD $8.92
  • NBTB $48.80
  • AVG Volume (30 Days)
  • MNKD 2.7M
  • NBTB 271.2K
  • Earning Date
  • MNKD 02-25-2025
  • NBTB 01-27-2025
  • Dividend Yield
  • MNKD N/A
  • NBTB 2.84%
  • EPS Growth
  • MNKD N/A
  • NBTB 0.14
  • EPS
  • MNKD 0.08
  • NBTB 2.85
  • Revenue
  • MNKD $267,200,000.00
  • NBTB $538,802,000.00
  • Revenue This Year
  • MNKD $45.45
  • NBTB N/A
  • Revenue Next Year
  • MNKD $16.45
  • NBTB $17.27
  • P/E Ratio
  • MNKD $75.81
  • NBTB $16.78
  • Revenue Growth
  • MNKD 51.35
  • NBTB 10.23
  • 52 Week Low
  • MNKD $3.17
  • NBTB $32.79
  • 52 Week High
  • MNKD $7.63
  • NBTB $52.44
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 37.75
  • NBTB 49.45
  • Support Level
  • MNKD $5.98
  • NBTB $44.78
  • Resistance Level
  • MNKD $6.32
  • NBTB $48.49
  • Average True Range (ATR)
  • MNKD 0.21
  • NBTB 1.27
  • MACD
  • MNKD -0.04
  • NBTB 0.02
  • Stochastic Oscillator
  • MNKD 20.55
  • NBTB 69.81

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. NBT Bank is a full-service community bank offering a full range of retail and commercial banking products and trust and investment services. Loan products include consumer, home equity, mortgage, business banking, and commercial loans. Nearly half of its loan portfolio is in commercial loans. The bank serves individuals, corporations, and municipalities, and operates scores of locations throughout New York, Pennsylvania, Vermont, Massachusetts, New Hampshire, and Maine.

Share on Social Networks: